Abstract

Treatment of 1,3-C6H4I2 with Pt(PEt3)4 in toluene leads to the isolation of [1,3-(Pt(PEt3)2I)2C6H4] (2). This complex has been characterized by 1H, 13C and 31P NMR and elemental analysis. The structure of 2 as well as that of [1,4-(Pt(PEt3)2I)2C6H4] (1) have been determined by single crystal X-ray analysis. As expected, the platinum centers of these derivatives adopt a square planar coordination geometry with the phosphine ligands in a trans arrangement. Treatment of compounds 1 and 2 with AgPF6 and subsequent addition of two equivalents of NITpPy (NITpPy = [2-(4-pyridyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide]) results in the formation of [1,4-(Pt(PEt3)2(NITpPy))2C6H4]2+[PF6]−2 (3) and [1,3-(Pt(PEt3)2(NITpPy))2C6H4]2+[PF6]−2 (4), respectively. Compounds 3 and 4 have been characterized by +ESI/TOF, IR, UV and elemental analysis. Their structures have been determined by X-ray crystallography which confirmed the coordination of a NITpPy ligand at each platinum center. As in 1 and 2, the platinum centers adopt a square planar coordination geometry with the phosphine ligands in a trans arrangement. As shown by EPR spectroscopy and SQUID magnetometry, intramolecular magnetic coupling of the coordinated NITpPy moieties does not occur.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.